AssetID: 54981753
Headline:
Caption:
Keywords: Health & Wellbeing,pancreatic cancer vaccine,early trial,immune response,KRAS mutation,survival rates,ELI-002 2P jab,treatment progress,bowel cancer,Nature Medicine,vaccine efficacy,clinical trial,cancer treatment,medical breakthrough,cancer research,patient survival,vaccine development,clinical research,immune therapy,medical innovation,survival improvement,cancer progression,oncology trials,healthcare advances,patient outcomes
PersonInImage: